Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents
Top Cited Papers
- 1 January 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (1) , 175-181
- https://doi.org/10.1016/j.jacc.2005.07.071
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Research on Adverse Drug Events and Reports (RADAR) ProjectPublished by American Medical Association (AMA) ,2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stentsThe Lancet, 2004
- Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and ReportingAnnals of Internal Medicine, 2004
- Coronary Uptake of Gallium-67 Citrate After Implantation of Sirolimus-Eluting StentCirculation, 2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary ArteriesCirculation, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995